Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Department of Health Science Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota.
J Am Coll Cardiol. 2019 Apr 16;73(14):1781-1791. doi: 10.1016/j.jacc.2019.01.053.
There are limited data on acute noncardiac multiorgan failure in cardiogenic shock complicating acute myocardial infarction (AMI-CS).
The authors sought to evaluate the 15-year national trends, resource utilization, and outcomes of single and multiple noncardiac organ failures in AMI-CS.
This was a retrospective cohort study of AMI-CS using the National Inpatient Sample database from 2000 to 2014. Previously validated codes for respiratory, renal, hepatic, hematologic, and neurological failure were used to identify single or multiorgan (≥2 organ systems) noncardiac organ failure. Outcomes of interest were in-hospital mortality, temporal trends, and resource utilization. The effects of every additional organ failure on in-hospital mortality and resource utilization were assessed.
In 444,253 AMI-CS admissions, noncardiac single or multiorgan failure was noted in 32.4% and 31.9%, respectively. Multiorgan failure was seen more commonly in admissions with non-ST-segment elevation AMI-CS, nonwhite race, and higher baseline comorbidity. There was a steady increase in the prevalence of single and multiorgan failure. Coronary angiography and revascularization were performed less commonly in multiorgan failure. Single-organ failure (odds ratio: 1.28; 95% confidence interval: 1.26 to 1.30) and multiorgan failure (odds ratio: 2.23; 95% confidence interval: 2.19 to 2.27) were independently associated with higher in-hospital mortality, greater resource utilization, and fewer discharges to home. There was a stepwise increase in in-hospital mortality and resource utilization with each additional organ failure.
There has been a steady increase in the prevalence of multiorgan failure in AMI-CS. Presence of multiorgan failure was independently associated with higher in-hospital mortality and greater resource utilization.
在合并急性心肌梗死(AMI-CS)的心源性休克的急性多器官非心源性衰竭方面,数据有限。
作者旨在评估 AMI-CS 中单器官和多器官(≥2 个器官系统)非心源性衰竭 15 年的全国趋势、资源利用和结局。
这是一项回顾性队列研究,使用 2000 年至 2014 年全国住院患者样本数据库,对 AMI-CS 患者进行研究。使用先前验证的呼吸、肾脏、肝脏、血液和神经系统衰竭的代码来识别单器官或多器官(≥2 个器官系统)非心源性器官衰竭。感兴趣的结局是院内死亡率、时间趋势和资源利用。评估每增加一个器官衰竭对院内死亡率和资源利用的影响。
在 444253 例 AMI-CS 住院患者中,分别有 32.4%和 31.9%的患者存在非心源性单器官或多器官衰竭。非 ST 段抬高 AMI-CS、非白人种族和更高基线合并症的住院患者中更常见多器官衰竭。单器官和多器官衰竭的患病率呈稳步上升趋势。多器官衰竭患者行冠状动脉造影和血运重建的比例较低。单器官衰竭(比值比:1.28;95%置信区间:1.26 至 1.30)和多器官衰竭(比值比:2.23;95%置信区间:2.19 至 2.27)与更高的院内死亡率、更多的资源利用和更少的出院回家独立相关。随着每增加一个器官衰竭,院内死亡率和资源利用呈逐步增加趋势。
AMI-CS 中多器官衰竭的患病率呈稳步上升趋势。多器官衰竭的存在与更高的院内死亡率和更多的资源利用独立相关。